The association between CD68+CD163+ macrophages and metastasis-free survival highlights the complexity of macrophage biology, given that CD163+ macrophages have traditionally been associated with worse outcomes in many solid tumors [32], including various sarcoma subtypes [33–35]. Here, CD163 is linked to sarcoma.